Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation.

Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Abstract Text:

    ivey thorntonIvey Thornton,ashok puriAshok Puri,meng xuMeng Xu,ronald r kruegerRonald R Krueger,

    PURPOSE: To evaluate the efficacy of low-dose (0.002%) mitomycin C (MMC) vs no prophylactic MMC (control) in reducing corneal haze after surface laser ablation. DESIGN: Two-year retrospective follow-up study performed in Jaipur, India. METHODS: Ninety-two eyes with no MMC application and 83 eyes with 0.002% MMC application during laser epithelial keratomileusis (LASEK) were analyzed in a retrospective chart review with one month, two months, three months, six months, one year, and two years of postoperative follow-up. Postoperative haze, visual acuity, and efficacy ratio (EFFR) then were analyzed statistically. RESULTS: The no-dose MMC and low-dose MMC groups were statistically similar except for a thinner corneal pachymetry (P < .001), higher spherical equivalent error (P = .006), and smaller ablation zone (P = .009) in eyes not treated with MMC when subjected to univariate analysis. Multivariate analysis was used to overcome the preoperative statistical differences among the two groups. Eyes treated with low-dose MMC (0.002%) demonstrated statistically less haze at all postoperative time points and in each myopic subgroup (P < .001). The postoperative uncorrected visual acuity (UCVA) and EFFR, however, showed no difference between the groups, except for better EFFR with MMC at one month (P < .001) and two months (P = .034). CONCLUSIONS: Low-dose MMC (0.002%) in eyes after LASEK results in less corneal haze than in eyes not receiving this agent. Concerns regarding the potential toxicity of MMC make a 10-fold less concentration more desirable in refractive surgery. Further comparative study of low- vs higher-dose MMC is recommended to characterize its clinical benefit fully.

    Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Publishing Authors By Initials

    i thorntonI Thornton,a puriA Puri,m xuM Xu,rr kruegerRR Krueger,

    For similar visual acuity research abstracts see: visual acuity research

    PUBMED ID PMID:

    MEDLINE DATE:

    Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: American journal of ophthalmology

    VOLUME: 144

    Page Numbers: 673-681

    Journal Abbreviation: Am. J. Ophthalmol.

    ISSN: 0002-9394

    DAY: 24

    MONTH: 09

    YEAR: 2007

    Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 370500

    Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Keywords Mesh Terms:

    KEYWORDS: Visual Acuity

    MESH TERMS: prevention & control

    Chemical & Substance for Abstract: Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Information

    Substance Name: Mitomycin

    Registry Number: 50-07-7

    Grant and Affiliation Information for Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation.

    AFFILIATION: Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Am J Ophthalmol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News